Fortfahren mit
Größe auswählen
| Ihnen/SKU | Verfügbarkeit | Preis |
|---|---|---|
400 mg | Warenkorb auf Verfügbarkeit prüfen | € 407,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
dobutamine
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
Cl[H].CC(CCc1ccc(O)cc1)NCCc2ccc(O)c(O)c2
InChI
1S/C18H23NO3.ClH/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15;/h4-9,12-13,19-22H,2-3,10-11H2,1H3;1H
InChI key
BQKADKWNRWCIJL-UHFFFAOYSA-N
Gene Information
human ... ADRB1(153), ADRB2(154)
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Application
- Dobutamine for Injection
- Dobutamine Hydrochloride
- Dobutamine in Dextrose Injection
- Dobutamine Injection
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade - |
| manufacturer/tradename USP | manufacturer/tradename EDQM | manufacturer/tradename BP | manufacturer/tradename - |
| format neat | format neat | format neat | format - |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical | application(s) - |
| Gene Information human ... ADRB1(153), ADRB2(154) | Gene Information human ... ADRB1(153), ADRB2(154) | Gene Information human ... ADRB1(153), ADRB2(154) | Gene Information human ... ADRB1(153), ADRB2(154) |
| API family dobutamine | API family dobutamine | API family dobutamine | API family - |
Still not finding the right product?
Explore all of our products under Dobutamin -hydrochlorid
signalword
Warning
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Repr. 2
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.


